Five-year results of randomized bioactive versus bare metal coils in the treatment of intracranial aneurysms: the Matrix and Platinum Science (MAPS) Trial.
Cameron G McDougallS Claiborne JohnstonSteven W HettsAnil GholkarStanley L BarnwellJuan Carlos Vazquez SuarezJavier Massó RomeroJohn C ChaloupkaAlain BonafeAjay K WakhlooDonatella TampieriChristopher F DowdAllan J FoxAquilla S Turknull nullPublished in: Journal of neurointerventional surgery (2020)
After 5 years Matrix2 coils were non-inferior to BMCs but no benefit was demonstrated. Post-treatment residual angiographic aneurysm filling (Raymond III) is strongly associated with TAR (P<0.0001) and post-treatment aneurysmal hemorrhage (P=0.008).